Clinical Trial Update: Evaluate the Effects of Dapagliflozin in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports completion of a study evaluating the effects of dapagliflozin in patients with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Type-2 Diabetes, Oral Antidiabetics | Phase 4 | Status: COMPLETED